It's typical for biotechs to sink after announcing stock offerings. And that's exactly what happened with Tyme Technologies stock last week. These declines make sense because the value of existing shares is diluted when more shares are issued.
Full Answer
Will Tyme stock price drop/fall?
Apr 22, 2022 · The Tyme Technologies Inc stock price fell by -3.25% on the last day (Friday, 22nd Apr 2022) from $0.33 to $0.32. and has now fallen 3 days in a row. During the day the stock fluctuated 5.97% from a day low at $0.31 to a day high of $0.33. The price has fallen in 6 of the last 10 days and is down by -4.52% for this period.
How much of Tyme Technologies'stock is owned by insiders?
Tyme Technologies, Inc. (NASDAQ:TYME) insider Steve Hoffman sold 78,125 shares of the companys stock in a transaction on Thursday, December 2nd. The shares were sold at an average price of $0.72, for a total transaction of $56,250.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
Is Tyme technologies (Tym) a good buy with a negative PE ratio?
Get the latest Tyme Technologies, Inc. (TYME) stock news and headlines to help you in your trading and investing decisions.
How often do you update the “Tyme” stock predictions?
Find the latest Tyme Technologies, Inc. (TYME) stock quote, history, news and other vital information to help you with your stock trading and investing.
Will Tyme stock go up?
The Wall Street analyst predicted that TYME TECHNOLOGIES's share price could reach $9.50 by Nov 13, 2021. The average TYME TECHNOLOGIES stock price prediction forecasts a potential upside of 2,814.11% from the current TYME share price of $0.33.
Does Tyme stock pay dividends?
Tyme Technologies (NASDAQ: TYME) does not pay a dividend.
How has Tyme Technologies' stock been impacted by Coronavirus (COVID-19)?
Tyme Technologies' stock was trading at $1.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health...
When is Tyme Technologies' next earnings date?
Tyme Technologies is scheduled to release its next quarterly earnings announcement on Thursday, June 9th 2022. View our earnings forecast for Tyme...
How were Tyme Technologies' earnings last quarter?
Tyme Technologies, Inc. (NASDAQ:TYME) announced its quarterly earnings results on Friday, February, 11th. The company reported ($0.03) earnings per...
Who are Tyme Technologies' key executives?
Tyme Technologies' management team includes the following people: Steve Hoffman , Chairman & Chief Science Officer ( LinkedIn Profile ) Richard...
Who are some of Tyme Technologies' key competitors?
Some companies that are related to Tyme Technologies include Antibe Therapeutics (ATBPD) , Pieris Pharmaceuticals (PIRS) , Shattuck Labs (STTK)...
What other stocks do shareholders of Tyme Technologies own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Tyme Technologies investors own include Rigel Pharmaceutic...
What is Tyme Technologies' stock symbol?
Tyme Technologies trades on the NASDAQ under the ticker symbol "TYME."
Who are Tyme Technologies' major shareholders?
Tyme Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include Millennium Management LLC...
Which institutional investors are selling Tyme Technologies stock?
TYME stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Kercheville Advisors LLC, Sus...
Signals & Forecast
The Tyme Technologies Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.
Support, Risk & Stop-loss
Tyme Technologies Inc finds support from accumulated volume at $1.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Tyme Technologies Inc stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.
What stocks does MarketBeat like better than Tyme Technologies?
Wall Street analysts have given Tyme Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tyme Technologies wasn't one of them.
Are investors shorting Tyme Technologies?
Tyme Technologies saw a decrease in short interest in the month of August. As of August 13th, there was short interest totaling 3,340,000 shares, a decrease of 31.7% from the July 29th total of 4,890,000 shares. Based on an average trading volume of 7,470,000 shares, the short-interest ratio is presently 0.4 days.
When is Tyme Technologies' next earnings date?
Tyme Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.#N#View our earnings forecast for Tyme Technologies.
How were Tyme Technologies' earnings last quarter?
Tyme Technologies, Inc. (NASDAQ:TYME) announced its quarterly earnings results on Tuesday, August, 10th. The company reported ($0.03) EPS for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.01.#N#View Tyme Technologies' earnings history.
How has Tyme Technologies' stock price been impacted by COVID-19 (Coronavirus)?
Tyme Technologies' stock was trading at $1.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TYME shares have increased by 0.0% and is now trading at $1.05.#N#View which stocks have been most impacted by COVID-19.
Who are some of Tyme Technologies' key competitors?
Some companies that are related to Tyme Technologies include Keros Therapeutics (KROS), Collegium Pharmaceutical (COLL), AnaptysBio (ANAB), Mersana Therapeutics (MRSN), Eagle Pharmaceuticals (EGRX), PyroGenesis Canada (PYR), Pliant Therapeutics (PLRX), Amryt Pharma (AMYT), Adagene (ADAG), Emisphere Technologies (EMIS), Silence Therapeutics (SLN), Lexicon Pharmaceuticals (LXRX), Altimmune (ALT), Rhythm Pharmaceuticals (RYTM) and Rigel Pharmaceuticals (RIGL).#N#View all of TYME's competitors..
What other stocks do shareholders of Tyme Technologies own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Tyme Technologies investors own include Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Allena Pharmaceuticals (ALNA), OpGen (OPGN), Selecta Biosciences (SELB), MEI Pharma (MEIP), Pfizer (PFE) and SCYNEXIS (SCYX)..
What You Need To Know Before Buying TYME Technologies Inc (NASDAQ: TYME) Stock
TYME Technologies is a new biotechnology company that develops “cancer metabolism-based therapies” or CMBTs. These treatments are designed to work across a wide range of diagnoses, solid tumors, hematologic cancers and more. The stock is trending higher after receiving patent notification for its metabolomic technology platform.
Tyme Technologies Skyrockets on Patent Claim Approval
Tyme Technologies says it received additional patent claims related to its metabolomic technology platform.
Here is What Hedge Funds Think About Tyme Technologies, Inc. (TYME)
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we’ve gathered as a result gives us access to a wealth of collective knowledge based on these firms’ portfolio holdings as of March 31st. In this […]
Here's Why We're Not Too Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Is Tyme Technologies, Inc.'s (NASDAQ:TYME) Shareholder Ownership Skewed Towards Insiders?
The big shareholder groups in Tyme Technologies, Inc. ( NASDAQ:TYME ) have power over the company. Insiders often own a...
Why Tyme Technologies Stock Is Taking Off Today
What happened Shares of Tyme Technologies (NASDAQ: TYME) were jumping 19.5% as of 11:45 a.m. EST on Tuesday. The solid gain came after the biotech announced the close of a public stock offering of 40 million shares.
Why Tyme Stock Got Demolished Today
Shares of Tyme Technologies (NASDAQ: TYME) were down by 36% as of 1:05 p.m. EST today, after the company reported fiscal third-quarter results. Tyme also launched an at-the-market (ATM) stock offering.
What is Tyme Technologies?
Tyme Technologies, Inc. (Nasdaq:TYME) (the "Company" or "TYME"), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today reported its conclusions from its recently conducted comprehensive strategic review and its fourth quarter and fiscal year 2021 financial results.
When is the TYME conference call?
TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET. TYME Technologies, Inc. (Nasdaq: TYME) (the "Company" or "TYME"), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTstm), today announced that it will host a conference call and live video webcast on ...
About TYME
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma.
Analyst Forecast
According to 2 analysts, the average rating for TYME stock is "Buy." The 12-month stock price forecast is 9.50, which is an increase of 755.86% from the latest price.
News
BEDMINSTER, N.J.-- (BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announ...
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe.
What's Happening With Tyme Technologies Inc Stock Today?
Tyme Technologies Inc (TYME) stock is trading at $2.20 as of 10:00 AM on Monday, Mar 15, a gain of $0.16, or 7.84% from the previous closing price of $2.04. The stock has traded between $2.10 and $2.27 so far today. Volume today is less active than usual. So far 512,049 shares have traded compared to average volume of 20,314,243 shares.